Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Arthur

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
BMC Cancer|February 7, 2014
Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogeneticsJiří Mayer, Christopher Arthur, Jacques Delaunay, et al.
Leukemia & Lymphoma|December 7, 2019
Prolonged administration of low-dose cytarabine and thioguanine in elderly patients with acute myeloid leukaemia (AML) achieves high complete remission rates and prolonged survivalChristopher Arthur, Anthony Jeffrey, Eva Yip, et al.
Ambio|September 22, 2022
Tracing innovation pathways behind fisheries co-management in VanuatuDirk J Steenbergen, Jacob Raubani, Sompert Gereva, et al.
American Journal of Hematology|May 3, 2024
Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphomaSam Yuen, Tycel J Phillips, Rajat Bannerji, et al.
Mbio|May 25, 2022
Penicillanic Acid Sulfones Inactivate the Extended-Spectrum β-Lactamase CTX-M-15 through Formation of a Serine-Lysine Cross-Link: an Alternative Mechanism of β-Lactamase InhibitionPhilip Hinchliffe, Catherine L Tooke, Christopher R Bethel, et al.
Ejhaem|July 18, 2022
Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndromeYandong Shen, Luke Coyle, Ian Kerridge, et al.
Science (New York, N.Y.)|December 5, 2015
Structure and membrane remodeling activity of ESCRT-III helical polymersJohn McCullough, Amy K Clippinger, Nathaniel Talledge, et al.
Bone Research|March 23, 2017
Clinical, cellular, microscopic, and ultrastructural studies of a case of fibrogenesis imperfecta ossiumMelissa L Barron, Mark S Rybchyn, Sutharshani Ramesh, et al.
Leukemia & Lymphoma|May 22, 2014
An imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trialJason D Lickliter, Kerry Taylor, Jeff Szer, et al.
Small (Weinheim an Der Bergstrasse, Germany)|February 16, 2021
De Novo Designed Peptide and Protein Hairpins Self-Assemble into Sheets and NanoparticlesJohanna M Galloway, Harriet E V Bray, Deborah K Shoemark, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
BMC Cancer|February 7, 2014
Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogeneticsJiří Mayer, Christopher Arthur, Jacques Delaunay, et al.
Leukemia & Lymphoma|December 7, 2019
Prolonged administration of low-dose cytarabine and thioguanine in elderly patients with acute myeloid leukaemia (AML) achieves high complete remission rates and prolonged survivalChristopher Arthur, Anthony Jeffrey, Eva Yip, et al.
Ambio|September 22, 2022
Tracing innovation pathways behind fisheries co-management in VanuatuDirk J Steenbergen, Jacob Raubani, Sompert Gereva, et al.
American Journal of Hematology|May 3, 2024
Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphomaSam Yuen, Tycel J Phillips, Rajat Bannerji, et al.
Mbio|May 25, 2022
Penicillanic Acid Sulfones Inactivate the Extended-Spectrum β-Lactamase CTX-M-15 through Formation of a Serine-Lysine Cross-Link: an Alternative Mechanism of β-Lactamase InhibitionPhilip Hinchliffe, Catherine L Tooke, Christopher R Bethel, et al.
Ejhaem|July 18, 2022
Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndromeYandong Shen, Luke Coyle, Ian Kerridge, et al.
Science (New York, N.Y.)|December 5, 2015
Structure and membrane remodeling activity of ESCRT-III helical polymersJohn McCullough, Amy K Clippinger, Nathaniel Talledge, et al.
Bone Research|March 23, 2017
Clinical, cellular, microscopic, and ultrastructural studies of a case of fibrogenesis imperfecta ossiumMelissa L Barron, Mark S Rybchyn, Sutharshani Ramesh, et al.
Leukemia & Lymphoma|May 22, 2014
An imatinib-only window followed by imatinib and chemotherapy for Philadelphia chromosome-positive acute leukemia: long-term results of the CMLALL1 trialJason D Lickliter, Kerry Taylor, Jeff Szer, et al.
Small (Weinheim an Der Bergstrasse, Germany)|February 16, 2021
De Novo Designed Peptide and Protein Hairpins Self-Assemble into Sheets and NanoparticlesJohanna M Galloway, Harriet E V Bray, Deborah K Shoemark, et al.
Pageof 3